<H1> Submit Your Nomination </H1> |
<H1> New nephSAP Issue </H1> |
<H1> Kidney Week 2023 </H1> |
<H1> Membership </H1> |
<H1> Prepare for the Boards </H1> |
<H1> American Society of Nephrology </H1> |
<H2> A World Without Kidney Diseases </H2> |
<H3> ASN's Mission </H3> |
<H3> Contact ASN </H3> |
<H3> The Latest on X </H3> |
<H3> ASN Midcareer Awards OpenApply by Friday, March 8 </H3> |
<H3> Pregnancy and Kidney Disease </H3> |
<H3> Kidney Week On-Demand™ </H3> |
<H3> Renew Your Membership </H3> |
<H3> BRCU Online 2023 Now Available </H3> |
<H3> Kidney Week On-Demand™ Is Now Available </H3> |
<H3> Renew Your ASN Membership for 2024 </H3> |
<H3> Face The Boards With Confidence </H3> |
<H3> Latest nephSAP: February 2024 </H3> |
<H3> Patient Perspectives of Skeletal Muscle Cramping in Dialysis: a Focus Group Study </H3> |
<H3> IVIVA Medical Acquired by United Therapeutics Corporation </H3> |
<H3> AKINow Journal Club </H3> |
<H3> Enriched Single-Nucleus RNA-Sequencing Reveals Unique Attributes of Distal Convoluted Tubule Cells </H3> |
<H3> Targeting APRIL in the Treatment of IgA Nephropathy </H3> |
<H3> Global Perspectives in Acute Kidney Injury: Sri Lanka </H3> |
<H3> Treating Patients with C3G or aHUS: ACE Inhibitors, AT1 Blockers, or Aliskiren? </H3> |
<H3> Friday, February 09, 2024 @ 8:44 AM </H3> |
<H3> Thursday, December 21, 2023 @ 5:33 PM </H3> |
<H3> Monday, December 04, 2023 @ 10:00 AM </H3> |
<H3> Monday, November 27, 2023 @ 2:56 PM </H3> |
<H3> Wednesday, November 22, 2023 @ 10:55 AM </H3> |
<H3> Research and Innovation Funding </H3> |
<H3> Transforming Dialysis Safety </H3> |
<H3> Catalyze Innovation and Treatment </H3> |
<H3> Innovation Accelerator </H3> |
<H3> Connect With ASN </H3> |
<H4> Nominate your peers now for their distinguished service as clinicians, educators, leaders, mentors, and researchers. </H4> |
<H4> The latest Nephrology Self-Assessment Program (nephSAP) issue, Volume 22: Issue 4 (Feb 2024): Pregnancy and Kidney Disease, is now available online. </H4> |
<H4> Kidney Week On-Demand™ is now available and provides online access to approximately
200 hours of Annual Meeting presentations from Kidney Week 2023, including plenary sessions,
basic and clinical science sessions, clinical practice sessions, special sessions,
and translational sessions. </H4> |
<H4> Renew your membership now for 2024, and maintain all of the great ASN benefits. </H4> |
<H4> ASN's Board Review Course & Update (BRCU) Online features all lectures from the
live course held in Chicago and will help you face the boards with confidence. </H4> |
<H4> Translate This Page </H4> |
<H5> RE: Question about resistant membranous nephropathy 2 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 2 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 2 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 5 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 6 hours ago </H5> |
<H5> RE: Is it safe to donate kidney? 6 hours ago </H5> |
<H5> RE: Hus 7 hours ago </H5> |
<H5> Is it safe to donate kidney? 7 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 8 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 10 hours ago </H5> |
<H5> RE: Hus 10 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 10 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 14 hours ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 14 hours ago </H5> |
<H5> RE: Seeking Advice regarding open trials for Genetic FSGS Patient 14 hours ago </H5> |
<H5> RE: Possibly inherited kidney disorder? 16 hours ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 16 hours ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 16 hours ago </H5> |
<H5> Seeking Advice regarding open trials for Genetic FSGS Patient 17 hours ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 18 hours ago </H5> |
<H5> RE: Nephrotic Syndrome 21 hours ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 1 day ago </H5> |
<H5> RE: 17 year old male with medullary calcification 1 day ago </H5> |
<H5> RE: Stone Analysis 1 day ago </H5> |
<H5> RE: Stone Analysis 1 day ago </H5> |
<H5> RE: 17 year old male with medullary calcification 1 day ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 1 day ago </H5> |
<H5> RE: 17 year old male with medullary calcification 1 day ago </H5> |
<H5> RE: 17 year old male with medullary calcification 1 day ago </H5> |
<H5> RE: 17 year old male with medullary calcification 1 day ago </H5> |
<H5> 17 year old male with medullary calcification 1 day ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 1 day ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 1 day ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 1 day ago </H5> |
<H5> RE: Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 1 day ago </H5> |
<H5> Fibrillary GN with + K/L ratio and negative SIEP, UIEP and (-) IF on bx 1 day ago </H5> |
<H5> RE: Sp kidney transplant with strep sepsis and acute GN 1 day ago </H5> |
<H5> RE: Sp kidney transplant with strep sepsis and acute GN 1 day ago </H5> |
<H5> RE: Sp kidney transplant with strep sepsis and acute GN 1 day ago </H5> |
<H5> RE: Possibly inherited kidney disorder? 1 day ago </H5> |
<H5> RE: Possibly inherited kidney disorder? 1 day ago </H5> |
<H5> RE: Sp kidney transplant with strep sepsis and acute GN 1 day ago </H5> |
<H5> RE: Lupus, Albuminuria, and persistently positive serologies: 1 day ago </H5> |
<H5> RE: Sp kidney transplant with strep sepsis and acute GN 1 day ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 1 day ago </H5> |
<H5> RE: Peritoneal Dialysis versus Hemodialysis in managing sever Pericardial Effusion 1 day ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 1 day ago </H5> |
<H5> RE: IgA nephropathy with predominant tubulointerstitial disease 1 day ago </H5> |
<H5> RE: Question about resistant membranous nephropathy 1 day ago </H5> |
<H5> RE: Peritoneal Dialysis versus Hemodialysis in managing sever Pericardial Effusion 1 day ago </H5> |
Social
Social Data
Cost and overhead previously rendered this semi-public form of communication unfeasible.
But advances in social networking technology from 2004-2010 has made broader concepts of sharing possible.